Press Release Distribution
Pricing
Customer Support
(800) 998-2927
Login
Log In
All Categories
Business
Entertainment
Health
Finance
Other
Tagged
antithrombotic
Press Release
Jul 19, 2021
Aronora Reports Positive Topline Data From Phase 2 Study of AB023 in Hemodialysis Patients
AB023 reduces dialyzer clotting compared to placebo during heparin-free dialysis, and continues to be safe and well tolerated
Read More
Press Release
Dec 2, 2020
Aronora Announces Clinical Data to Be Presented at the 62nd American Society of Hematology Annual Meeting
Presentation to include clinical data from Aronora's phase 2 study of AB023, a factor XI-targeted antibody that is being developed for the treatment and prevention of thrombosis and inflammation.
Read More
Press Release
Sep 26, 2018
Aronora's New Blood Clot Treatment Receives FDA Fast Track Designation
Enzyme that selectively targets blood clots has received FDA Fast Track designation, allowing for expedited clinical development
Read More
Press Release
Sep 8, 2011
A New Series Of Reports From EMR Provide An In-depth Insight On Key Emerging Antithrombotic Markets
EMR's latest publications provide an exceptional tool to understand the current trends, therapeutic structure, competitive landscape and the outlook for key emerging antithrombotic drug markets till 2016.
Read More
First
Prev
1
Next
Last